Fill-Finish for Biosimilars: Ready, Set, Develop!
The last four years have seen remarkable developments in the field of cell and gene therapy. In 2019, the FDA forecasted that the US is likely to add 10-20 cell and gene therapies per year until 2025, and current prognostication has development tracking at that speed.
503 Pharmacies: Integral Partners in the Healthcare Industry
The last four years have seen remarkable developments in the field of cell and gene therapy. In 2019, the FDA forecasted that the US is likely to add 10-20 cell and gene therapies per year until 2025, and current prognostication has development tracking at that speed.
Cell and Gene Therapy: 2023 and Beyond
The last four years have seen remarkable developments in the field of cell and gene therapy. In 2019, the FDA forecasted that the US is likely to add 10-20 cell and gene therapies per year until 2025, and current prognostication has development tracking at that speed.
Gloved vs. Gloveless Aseptic Filling Machines
When deciding on an aseptic fill/finish machine, the choice to use a gloved or gloveless isolator will arise – and we want to help with that decision. There are a few attributes to consider when choosing between a gloved or a gloveless isolator.
4 Factors to Consider when Scaling Up
Moving forward to the next phases of clinical trials is an extremely exciting and hectic time. Understanding how scaling up affects your aseptic filling operations is essential. Here are 4 topics to consider that will help ensure that your drug product will be taken care of and be ready for production while increasing your ROI.
7 Things to Know When Evaluating Small-Scale Aseptic Filling Technology
Small-scale aseptic filling presents its own unique set of challenges. There are questions like “how fast do you need your machines to run?” or “What kind of material do you need to process?” Those types of questions can lead to other ones that possibly have more complicated answers. To help, we’ve broken down 7 things […]
Challenges Facing Aseptic Manufacturing in the Cell and Gene Therapy Market
Cell and gene therapies continue to gain significant traction in the biopharmaceutical world. While this technology continues to grow, challenges will inevitably follow. When it comes to aseptic fill/finish challenges, these 4 are ones to consider: